Get A Good Night’s Snooze: This Company Secures First-Ever US Patent For Marijuana Sleep Product

June 21, 2023 · Benzinga

Curio Wellness, a cGMP-certified, vertically integrated cannabis company, has been granted the first-ever US patent for its cannabis sleep product, Good Night by Curio.

The patent, designated as Utility Patent 11,654,130, was awarded to Curio Wellness on May 23, 2023, and will remain in force until January 2042, per a press release.

Good Night, the cannabis sleep aid line available in Maryland has been leading the market since its introduction in 2021. The product, in the form of ratio tablets, is designed to help consumers fall asleep more quickly, stay asleep for longer and minimize morning grogginess.

Curio Wellness’ patented technology secures a distinctive pulse-delivery system for medicinal cannabis sleep products.

“This patent validates the revolutionary nature of the product development efforts at Curio and the novel application of our pulse-release technology,” said Dr. Edward Rudnic, chairman of Curio’s scientific board and its chief scientific officer.

Michael Bronfein, CEO of Curio Wellness and co-inventor, called the patent a milestone. “This patent is a significant and exciting milestone for Curio, and solidifies our commitment to developing cutting-edge cannabis products that enable our patients to enjoy a better quality of life.”

Curio Wellness, based in Maryland, is recognized as the leading developer of cannabis-derived medical products in the state. (Full Story)

In categories:Business Lifestyle
Next Post

Colorado Cannabis Market Shows First Price Rise Since 2021, Ducking Deflation

Prices have been on a rapid slide since the summer of 2021, reaching record lows by the end of last year. After nearly a two-year stretch of deflation, marijuana prices in Colorado are showing the first signs of life since…
Previous Post

More states reduce 280E tax burden on cannabis industry

The U.S. cannabis industry is benefiting from long-desired tax relief now that an increasing number of states – 20 so far – have approved laws that exempt, or “decouple,” businesses from Section 280E of the federal tax code. This spring,…
Random Post

Virginia Judge Rejects Injunction on Law Limiting Delta-8, Total THC in Hemp Products

Since the 2018 Farm Bill authorized hemp production and removed the crop from the Drug Enforcement Administration’s (DEA) schedule of Controlled Substances, the hemp-derived cannabinoid industry has boomed across the nation — including the sale of hemp-derived, psychoactive delta-8 and…
Random Post

Top Pharmacists Association Endorses Drug Decriminalization

The American Pharmacists Association (APhA) is officially backing the decriminalization of all drugs and paraphernalia, earning the praise of drug reform and harm reduction advocates. Members of APhA’s House of Delegates voted to adopted the revised policy late last month,…
Random Post

Tilray Triples Beverage Portfolio with $85M Anheuser-Busch Deal

Canadian megacorp Tilray Brands Inc. struck an $85-million cash deal with Budweiser parent company Anheuser-Busch InBev (AB InBev) to purchase eight breweries in the United States. The acquisition will triple Tilray’s beverage production capacity to 12 million cases per year,…
Random Post

NCAA Committee Recommends Removing Cannabis from Banned Substances List

The NCAA Committee on Competitive Safeguards and Medical Aspects of Sports (CMAS) last week recommended removal of cannabis from its list of banned substances for all three divisions, calling instead for a “robust educational strategy.” The organization first announced in June they…